Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001008161-05-000001
Filing Date
2005-03-21
Accepted
2005-03-21 12:25:57
Documents
1
Period of Report
2005-03-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3003
  Complete submission text file 0001008161-05-000001.txt   4930
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Issuer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1617 JFK BLVD SUITE 660 PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD SUITE 660 PHILADELPHIA PA 19103
CARTER WILLIAM A (Reporting) CIK: 0001008161 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13441 | Film No.: 05693538